IPCA Laboratories' shares rise 7% after strong earnings in the December 2024 quarter.
IPCA Labs stock reaches an intraday high of ₹1,524.85 on NSE, ending four days of losses.
The company reports a 38% YoY net profit growth to ₹248 crore from ₹180 crore last year.
Revenue from operations increased to ₹2,245.4 crore, up from ₹2,053 crore last year.
IPCA Labs posts solid growth in profit and revenue, boosting investor confidence.